Schizophrenia
6.0
来源：
Nature
关键字：
neuromodulation
发布时间：
2025-11-27 15:36
摘要：
Schizophrenia is a complex mental health disorder with a lifetime prevalence of 0.4%, often emerging in late adolescence or early adulthood. It presents significant treatment challenges due to its diverse manifestations and frequent treatment resistance. Recent advancements include the approval of medications targeting neurotransmitter systems beyond dopamine and innovative approaches like virtual reality therapies. The article emphasizes the need for ongoing research into the neurobiological underpinnings of schizophrenia and the development of effective treatment strategies.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
0.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
1.0
market_value_relevance
1.0
team_institution_background
0.0
technical_barrier_competition
0.0
关键证据
Schizophrenia has a lifetime prevalence of 0.4%.
The first medication targeting neurotransmitter systems other than dopamine has been approved.
Current attempts to use virtual reality and avatars to improve psychotic symptoms seem promising.
真实性检查
否
AI评分总结
Schizophrenia is a complex mental health disorder with a lifetime prevalence of 0.4%, often emerging in late adolescence or early adulthood. It presents significant treatment challenges due to its diverse manifestations and frequent treatment resistance. Recent advancements include the approval of medications targeting neurotransmitter systems beyond dopamine and innovative approaches like virtual reality therapies. The article emphasizes the need for ongoing research into the neurobiological underpinnings of schizophrenia and the development of effective treatment strategies.